TriSalus Life Sciences annual current ratio
2021
2022
2023
2024
2025
TriSalus Life Sciences Current Ratio Growth & History (TLSI)
TriSalus Life Sciences's current ratio was 2.80 for fiscal 2025.
View full TriSalus Life Sciences company overviewTriSalus Life Sciences annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 2.80 | 0.78 | +38.76% |
| 2024 | 2024-12-31 | 2.02 | 0.60 | +42.27% |
| 2023 | 2023-12-31 | 1.42 | 0.89 | +167.00% |
| 2022 | 2022-12-31 | 0.53 | 0.20 | +62.02% |
| 2021 | 2021-12-31 | 0.33 | — | — |
TriSalus Life Sciences quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.35 | 1.26 | +30.93% |
| Q1 2026 | 2026-03-31 | 5.78 | 3.65 | +170.75% |
| Q4 2025 | 2025-12-31 | 2.80 | 0.78 | +38.76% |
| Q3 2025 | 2025-09-30 | 3.05 | 0.65 | +27.26% |
| Q2 2025 | 2025-06-30 | 4.08 | 1.76 | +75.38% |
| Q1 2025 | 2025-03-31 | 2.14 | 1.22 | +133.00% |
| Q4 2024 | 2024-12-31 | 2.02 | 0.60 | +42.27% |
| Q3 2024 | 2024-09-30 | 2.40 | −0.72 | −23.09% |
| Q2 2024 | 2024-06-30 | 2.33 | 2.30 | +8600.48% |
| Q1 2024 | 2024-03-31 | 0.92 | 0.85 | +1320.62% |
| Q4 2023 | 2023-12-31 | 1.42 | 0.89 | +167.00% |
| Q3 2023 | 2023-09-30 | 3.12 | 2.96 | +1850.48% |
| Q2 2023 | 2023-06-30 | 0.03 | −0.13 | −82.54% |
| Q1 2023 | 2023-03-31 | 0.06 | −0.10 | −61.29% |
| Q4 2022 | 2022-12-31 | 0.53 | 0.20 | +62.02% |
| Q3 2022 | 2022-09-30 | 0.16 | — | — |
| Q2 2022 | 2022-06-30 | 0.15 | — | — |
| Q1 2022 | 2022-03-31 | 0.17 | — | — |
| Q4 2021 | 2021-12-31 | 0.33 | — | — |
TriSalus Life Sciences current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, TriSalus Life Sciences's current ratio increased from 0.33 to 2.80, a change of 2.48. The latest reported quarter, Q2 2026, shows 5.35.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TriSalus Life Sciences source filings ↗